pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·11h ago·1 min read
save

Why Biopharma Executives Should Hire an ‘Implementer’ to Turn Ideas into Action

Aug 19, 2026·read at BioSpace ↗Positive

Leadership Lab is a new column aimed at biopharma leaders facing real‑world pressures. In the opening piece, Michael Pietrack of Kaye/Bassman International argues that the most valuable hire for an executive may be the person who can execute ideas.

He recounts a meeting with a biotech founder who could explain complex science to any audience but struggled to prioritize and move his many concepts forward. The gap between idea generation and implementation, Pietrack notes, is becoming more common.

Pietrack calls this missing role the “implementer” – a professional who translates vision into concrete projects, decides which ideas merit resources, and drives them to completion. He suggests that hiring an implementer can improve team performance and overall organizational outcomes.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Leadership Lab: The one person executives need by their side”

read at BioSpace ↗
1,287 words · retrieved 11h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING
topics
Ophthalmology2

related stories

  • Jul 28An eye drug biotech banks $118M and stocks its executive suiteBioPharma Dive
  • Jul 28STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDSTAT
  • Jul 27Sarepta names former AbbVie R&D exec Michael Severino as next CEOBioSpace
  • Jul 27Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEOBioPharma Dive
  • Jul 27Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drugFierce Biotech